Multicellular living organisms and unmodified parts thereof and – Nonhuman animal
Reexamination Certificate
2008-07-22
2008-07-22
Wilson, Michael C. (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
C800S013000
Reexamination Certificate
active
11054358
ABSTRACT:
Methods and compositions for identifying an agent (e.g., a gene product or small molecule compound) that modulates a Parkinson's disease phenotype are provided. In practicing the subject methods, a non-mammalian animal model, such asDrosophila melanogaster, that includes a mutant parkin gene and at least one other mutant gene are evaluated for a Parkinson's disease phenotype. Also provided are kits, and systems for practicing the subject methods, as well as methods of use of agents identified in the screening method of the invention.
REFERENCES:
patent: 6812248 (2004-11-01), Zhang et al.
patent: 6943278 (2005-09-01), Chung
patent: 2004/0073955 (2004-04-01), Chung
patent: 2004/0205833 (2004-10-01), Klein et al.
patent: 2006/0174356 (2006-08-01), Pallanck et al.
Cordato (J. Clinical Nuerosci., Feb. 2004, vol. 11, No. 2, p. 119-123).
Lockhart (Movement disorders, Jan. 2004, vol. 19, No. 1, p. 101-104).
Whitworth (PNAS, May 31, 2005, vol. 102, No. 22, p. 8024-8029).
Stroombergen et al. Determination of glutathione S-transferease μ and O polymorphisms in neurological disease. Human & Experimental Toxicology (1999) vol. 18, pp. 141-145.
Auluck et al., Pharmacological prevention of Parkinson disease in Drosophila, Nat. Med. 8(11):1185-1186 (2002).
Feany et al., “A drosophila model of parkinson' s disease”, Nature, 404(6776):394-398 (2000).
Giasson et al., “Are ubiquitination pathways central to parkinson's disease”, Cell, 114(1):1-8 (2003).
Giasson et al., “Parkin and the molecular pathways of parkinson's disease”, Neuron, 31(6):885-888 (2001).
Goldberg et al., “Is there a cause-and-effect relationship between α-synuclein fibrillization and parkinson'disease”, Nat. Cell Biol., 2(7):E115-119 (2000).
Greene et al., “Mitochondrial pathology and apoptotic muscle degeneration in drosophila parkin mutants”, PNAS, 100(7):4078-4083 (2003).
Haywood et al., “Parkin counteracts symptoms in a drosophila model of parkinson's disease”, BMC Neuroscience, 5:14 (2004).
Link, “Transgenic invertebrate models of age-associated neurodegenerative diseases”, Mech. Ageing Dev., 122(14):1639-1649 (2001).
Muqit et al., “Modeling neurodegenerative diseases in drosophila: a fruitful approach”, Nat. Rev. Neurosci., 3(3):237-243 (2002).
Pendleton et al., “Effects of pharmacological agents upon a transgenic model of parkinson's disease in drosophila melanogaster”, J. Pharm. Exper. Ther., 300(1): 91-96 (2002).
Pesah et al., “Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress”, Development and Disease 131(9):2183-2194 (2004).
Scherzer et al., “Gene expression changes presage neurodegeneration in a drosophila model of parkinson's disease”, Hum. Mol. Genetics, 12(19):2457-2466 (2003).
Wanker, “Protein aggregation in huntington's and parkinson's disease: implications for therapy”, Mol. Med. Today, 6(10):387-391 (2000).
West et al., “Genetics of parkin-linked disease”, Hum. Genet., 114(4):327-336 (2004).
Deng Y. et al. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett. Aug. 19, 2004;366(3):326-31.
Haass and Kahle. Parkinson's pathology in a fly.Nature, Mar. 23, 2000;404(6776):341, 343.
Hattori et al. Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet. Aug. 21-27, 2004;364(9435):722-4.
Kelada et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett. Jan. 30, 2003;337(1):5-8.
Li et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. Dec. 15, 2003;12(24):3259-67. Epub Oct. 21, 2003.
Menegon et al. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet. Oct. 24, 1998;352(9137):1344-6.
von Bohlen Und Halbach O. Prog Neurobiol. Genes, proteins, and neurotoxins involved in Parkinson's disease. Jun. 2004;73(3):151-77.
Vila A. and S. Przedborski. Genetic clues to the pathogenesis of Parkinson's disease. Nat Med. Jul. 2004;10 Suppl:S58-62.
Pallanck Leo J.
Whitworth Alexander J.
Zuniga Jessica G.
Bozicevic Field & Francis LLP
Francis Carol L.
The University of Washington
Wilson Michael C.
LandOfFree
Methods and compositions for screening for modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for screening for modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for screening for modulators of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3947486